Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2001 | 1 |
2003 | 2 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
An EORTC-ECSG phase I study of LU 79553 administered every 21 or 42 days in patients with solid tumours.
Eur J Cancer. 2003 Apr;39(6):742-7. doi: 10.1016/s0959-8049(02)00776-1.
Eur J Cancer. 2003.
PMID: 12651198
Clinical Trial.
UFT and leucovorin in first-line chemotherapy for patients with metastatic gastric cancer. An Early Clinical Studies Group (ECSG)/European Organization for Research Treatment of Cancer (EORTC) phase II trial.
Ravaud A, Borner M, Schellens JH, Geoffrois L, Schöffski BP, Kroon K, Wanders J, Hanauske AR, Fumoleau P; EORTC-ECSG.
Ravaud A, et al.
Eur J Cancer. 2001 Sep;37(13):1642-7. doi: 10.1016/s0959-8049(01)00187-3.
Eur J Cancer. 2001.
PMID: 11527690
Clinical Trial.
Item in Clipboard
Phase II study of XR 5000 (DACA), an inhibitor of topoisomerase I and II, administered as a 120-h infusion in patients with non-small cell lung cancer.
Dittrich C, Coudert B, Paz-Ares L, Caponigro F, Salzberg M, Gamucci T, Paoletti X, Hermans C, Lacombe D, Fumoleau P; European Organization for Research and Treatment of Cancer--Early Clinical Studies Group/New Drug Development Programme (EORTC-ECSG/NDDP).
Dittrich C, et al.
Eur J Cancer. 2003 Feb;39(3):330-4. doi: 10.1016/s0959-8049(02)00559-2.
Eur J Cancer. 2003.
PMID: 12565985
Clinical Trial.
Item in Clipboard
Cite
Cite